ライフサイエンスコーパス: induced pluripotent stem cell

1 ramming procedures that yield low numbers of induced pluripotent stem cells.

2 epigenome in single embryonic stem cells and induced pluripotent stem cells.

3 embryonic fibroblasts are reprogrammed into induced pluripotent stem cells.

4 from individuals with nonsyndromic ASD using induced pluripotent stem cells.

5 s in cerebral organoids generated from human-induced pluripotent stem cells.

6 878 and small populations of fibroblasts and induced pluripotent stem cells.

7 conversion of mouse embryonic stem cells and induced pluripotent stem cells.

8 topoietic abnormalities with patient-derived induced pluripotent stem cells.

9 from human neural progenitor cells and human induced pluripotent stem cells.

10 ecting ducts, stroma, and vasculature - from induced pluripotent stem cells.

11 t, from mouse embryonic stem cells and human induced pluripotent stem cells.

12 or by reprogramming somatic cells to become induced pluripotent stem cells.

13 in protocols for neuron differentiation from induced pluripotent stem cells allowed us to elucidate t

14 , A243T) were generated from patient-derived induced pluripotent stem cells and compared with wild-ty

15 diomyocytes derived from nontransgenic human induced pluripotent stem cells and generated tissues of

16 Here, the authors show in induced pluripotent stem cells and mouse knockouts that

17 bo-H in stem cells (embryonic stem cells and induced pluripotent stem cells) and various normal and c

18 multiple hPSC lines, including embryonic and induced pluripotent stem cells, and it takes approximate

19 Using induced pluripotent stem cells, Ang et al. elucidate how

20 The induced pluripotent stem cells approach allows compariso

21 he redifferentiation of four patient-derived induced pluripotent stem cells as a model for the onset

22 Here we use an human-induced pluripotent stem cell-based platform to demonstr

23 ed a frontotemporal dementia patient-derived induced pluripotent stem cell carrying the Tau P301L mut

24 nd facilitates the generation of more robust induced pluripotent stem cells, characterized by enhance

25 Induced pluripotent stem cells could potentially help to

26 Human induced pluripotent stem cell derived cardiomyocytes (hi

27 Induced pluripotent stem cell derived cardiomyocytes (iP

28 el in HEK293 cells and also overexpressed in induced pluripotent stem cells derived cardiomyocytes (i

29 ticipants: Neurons differentiated from human-induced pluripotent stem cells derived from 4 individual

30 glial progenitor cells (GPCs) produced from induced pluripotent stem cells derived from patients wit

31 t and structural interconnectivity, based on induced pluripotent stem cells derived from the respecti

32 ncoded by PCSK1) were reduced in PWS patient induced pluripotent stem cell-derived (iPSC-derived) neu

33 21085 on expression of nearby genes in human induced pluripotent stem cell-derived (iPSC-derived) neu

34 d pluripotent stem cells to generate a human-induced pluripotent stem cell-derived cardiac muscle pat

35 al, and force generation properties of human-induced pluripotent stem cell-derived cardiac tissues.

36 r synchronization within maturing, unlabeled induced pluripotent stem cell-derived cardiomyocyte cult

37 Mapping of induced pluripotent stem cell-derived cardiomyocyte netw

38 In human induced pluripotent stem cell-derived cardiomyocytes (hi

39 Despite increased use of human induced pluripotent stem cell-derived cardiomyocytes (hi

40 Human induced pluripotent stem cell-derived cardiomyocytes (hi

41 Human induced pluripotent stem cell-derived cardiomyocytes (hi

42 nclinical studies of drug effects with human induced pluripotent stem cell-derived cardiomyocytes (hi

43 RATIONALE: Human-induced pluripotent stem cell-derived cardiomyocytes (hi

44 g rate and decreased beat amplitude in human induced pluripotent stem cell-derived cardiomyocytes (hi

45 eate biological pacemakers in animal models, induced pluripotent stem cell-derived cardiomyocytes (iP

46 onditions to generate EHM from embryonic and induced pluripotent stem cell-derived cardiomyocytes and

47 support the seeding and engraftment of human induced pluripotent stem cell-derived cardiomyocytes and

48 tion of functionalvs remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and

49 monstrated that commercially available human induced pluripotent stem cell-derived cardiomyocytes are

50 and also supports the use of isogenic human induced pluripotent stem cell-derived cardiomyocytes as

51 The patient-derived induced pluripotent stem cell-derived cardiomyocytes dis

52 d characterized the functional properties of induced pluripotent stem cell-derived cardiomyocytes fro

53 d characterized the functional properties of induced pluripotent stem cell-derived cardiomyocytes fro

54 regulated in rodent cardiomyocytes and human induced pluripotent stem cell-derived cardiomyocytes in

55 Human-induced pluripotent stem cell-derived cardiomyocytes pro

56 modeling and heart repair from embryonic and induced pluripotent stem cell-derived cardiomyocytes und

57 2 expression produced a functional rescue in induced pluripotent stem cell-derived cardiomyocytes wit

58 d was seeded with approximately 50 000 human-induced pluripotent stem cell-derived cardiomyocytes, sm

59 Using human induced pluripotent stem cell-derived cardiomyocytes, we

60 ed the role of TLR3-IFN immunity using human induced pluripotent stem cell-derived cardiomyocytes.

61 s, adult rat ventricular myocytes, and human induced pluripotent stem cell-derived CMs, decreasing ex

62 ouse cells, patient-derived fibroblasts, and induced pluripotent stem cell-derived dopaminergic neuro

63 Native pulmonary arterial and induced pluripotent stem cell-derived endothelial cells

64 isease in the lung, our study indicates that induced pluripotent stem cell-derived endothelial cells

65 Here, we used comparison of induced pluripotent stem cell-derived endothelial cells

66 larizing native intestinal matrix with human induced pluripotent stem cell-derived epithelium and hum

67 mammalian cells, including in vitro cultured induced pluripotent stem cell-derived forebrain neurons

68 se three molecules were downregulated in the induced pluripotent stem cell-derived forebrain neurons

69 tylhydroxytoluene, in endocrine-active human-induced pluripotent stem cell-derived foregut epithelial

70 DE11A), and lithium decreases PDE11A mRNA in induced pluripotent stem cell-derived hippocampal neuron

71 e examined the BM homing properties of human induced pluripotent stem cell-derived HSPCs (hiPS-HSPCs)

72 ellularized rat intestinal matrix with human induced pluripotent stem cell-derived intestinal epithel

73 s and specific ones are deregulated in human-induced pluripotent stem cell-derived MNs carrying the F

74 phenotype in patient-derived fibroblasts and induced pluripotent stem cell-derived motor neurons.

75 human SH-SY5Y neuroblastoma cells and human induced pluripotent stem cell-derived motor neurons.

76 Induced pluripotent stem cell-derived neural stem cells

77 neuronal stretch injury model employs human induced pluripotent stem cell-derived neurons (hiPSCNs)

78 in schizophrenia-associated vs control human-induced pluripotent stem cell-derived neurons and 1199 g

79 e morphology of mice hippocampal neurons and induced pluripotent stem cell-derived neurons from a pat

80 Similarly, induced pluripotent stem cell-derived neurons from a pat

81 xplored the underlying pathophysiology using induced pluripotent stem cell-derived neurons from AS pa

82 ble knockdown of Parkin or SLP-2, as well as induced pluripotent stem cell-derived neurons from Parki

83 d mitophagy, which is also apparent in human induced pluripotent stem cell-derived neurons, a disease

84 t possess greater protective effect in human induced pluripotent stem cell-derived neurons, protectin

85 These findings were corroborated in induced pluripotent stem cell-derived neurons, providing

86 fashion, but also exacerbated cell death in induced pluripotent stem cell-derived primary human neur

87 e have established conditions by which human induced pluripotent stem cell-derived sensory neurons ca

88 channel expressed in either rodent or human induced pluripotent stem cell-derived sensory neurons in

89 ssion of type III neuregulin-1 (TIIINRG1) in induced pluripotent stem cell-derived sensory neurons st

90 Myelinating co-cultures using human induced pluripotent stem cell-derived sensory neurons th

91 al ordering of human embryonic stem cell and induced pluripotent stem cell-derived single-cell gene e

92 ed doxorubicin-induced cytotoxicity in human induced pluripotent stem cells-derived cardiomyocytes (i

93 that involved mouse mesencephalic and human induced pluripotent stem cells-derived DA neurons.

94 naling in both mouse mesencephalic and human induced pluripotent stem cells-derived DA neurons.

95 an cardiac phenotypes from data generated in induced-pluripotent-stem-cell-derived myocytes from fami

96 ression of Nudt21 enhanced the generation of induced pluripotent stem cells, facilitated transdiffere

97 cells and shares conserved domains with the induced pluripotent stem cell factor Lin28 in mammals.

98 GATA4 was interrupted by CRISPR-Cas9 in induced pluripotent stem cells from healthy donors.

99 Using motor neurons derived from induced pluripotent stem cells from patients with ALS an

100 found that human neurons differentiated from induced pluripotent stem cells from patients with Rett s

101 rved in neural progenitor cells derived from induced pluripotent stem cells from schizophrenia patien

102 standards of access to and quality of human induced pluripotent stem cells has lagged behind their u

103 Induced pluripotent stem cells have great potential as a

104 Treatment of patient-derived induced pluripotent stem cell-hepatic cells with a JNK i

105 3243A > G mutation to generate heteroplasmic induced pluripotent stem cell (hiPSC) clones.

106 ntional hESC and transgene-independent human induced pluripotent stem cell (hiPSC) lines could be rev

107 in a discovery cohort of 25 phenotyped human induced pluripotent stem cell (hiPSC) lines revealed uni

108 ast cells from families of donors into human induced pluripotent stem cell (hiPSC) lines.

109 aimed to establish a patient-specific human induced pluripotent stem cell (hiPSC) model of CPVT2 and

110 Human induced pluripotent stem cell (hiPSC) utility is limited

111 The power of human induced pluripotent stem cell (hiPSC)-based studies to r

112 e compounds, gentamicin and PTC124, in human-induced pluripotent stem cell (hiPSC)-derived cardiomyoc

113 bB2/4 mouse model of SZ, as well as in human induced pluripotent stem cell (hiPSC)-derived forebrain

114 Human induced pluripotent stem cells (hiPSc) are a very useful

115 Human induced pluripotent stem cells (hiPSC) represent a power

116 nous proteins with fluorescent tags in human induced pluripotent stem cells (hiPSC).

117 derived from human embryonic stem cells and induced pluripotent stem cells (hiPSC).

118 ulation of cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs), 41 were accu

119 o address this, we generated panels of human induced pluripotent stem cells (hiPSCs) and hiPSC-derive

120 w using a stage-matching approach that human induced pluripotent stem cells (hiPSCs) and human embryo

121 bility to generate cardiomyocytes from human induced pluripotent stem cells (hiPSCs) and human embryo

122 Human induced pluripotent stem cells (hiPSCs) are invaluable t

123 Human-induced pluripotent stem cells (hiPSCs) can be different

124 loading/dye transfer assay showed that human induced pluripotent stem cells (hiPSCs) contained functi

125 e cells can be generated in vitro from human induced pluripotent stem cells (hiPSCs) derived from pat

126 ed cardiac tissue (LF-ECT) composed of human induced pluripotent stem cells (hiPSCs) derived multiple

127 activity that can specifically detect human induced pluripotent stem cells (hiPSCs) down to a spiked

128 We report the derivation of human-induced pluripotent stem cells (hiPSCs) from patients wi

129 Human induced pluripotent stem cells (hiPSCs) have potential f

130 Genome editing of human induced pluripotent stem cells (hiPSCs) offers unprecede

131 otocols for hepatic differentiation of human induced pluripotent stem cells (hiPSCs) result in low yi

132 nt stem cells in vitro, including from human induced pluripotent stem cells (hiPSCs).

133 DAPT to induce SE differentiation from human induced pluripotent stem cells (hiPSCs).

134 gulates cardiomyocyte development from human induced pluripotent stem cells (hiPSCs).

135 functional human beige adipocytes from human induced pluripotent stem cells (hiPSCs).

136 ic stem cells (HSCs) could be generated from induced pluripotent stem cells in vitro.

137 The Human Induced Pluripotent Stem Cell Initiative (HipSci) isf es

138 ed from 301 healthy individuals by the Human Induced Pluripotent Stem Cells Initiative.

139 vo, and is sufficient to differentiate human induced pluripotent stem cells into electrophysiological

140 Directing the differentiation of induced pluripotent stem cells into motor neurons has al

141 , we transplanted TM-like cells derived from induced pluripotent stem cells into the anterior chamber

142 Technology utilizing human induced pluripotent stem cells (iPS cells) has enormous

143 , including non-dividing primary neurons and induced-pluripotent stem cells (iPS).

144 f7 at cilia tips detected in fibroblasts and induced pluripotent stem cell (iPSC) 3D optic cups deriv

145 employed isogenic human RTT patient-derived induced pluripotent stem cell (iPSC) and MeCP2 short hai

146 In RNAseq experiments of human induced pluripotent stem cell (iPSC) derived cardiomyocy

147 2/3 significantly improves the efficiency of induced pluripotent stem cell (iPSC) generation by the Y

148 of wild-type and mutant RTT patient-specific induced pluripotent stem cell (iPSC) line carrying the V

149 In this study, we derived a collection of induced pluripotent stem cell (iPSC) lines capturing a r

150 We created induced pluripotent stem cell (iPSC) lines from 1 patien

151 g and gene expression profiling of 215 human induced pluripotent stem cell (iPSC) lines from differen

152 Variability in induced pluripotent stem cell (iPSC) lines remains a con

153 ncy may lead to deleterious DNA mutations in induced pluripotent stem cell (iPSC) lines, which would

154 Ps on miRNA regulation was also confirmed in induced pluripotent stem cell (iPSC) lines.

155 ocessed three C1 replicates from three human induced pluripotent stem cell (iPSC) lines.

156 s of the study were to establish an in vitro induced pluripotent stem cell (iPSC) model of TTS, to te

157 While induced pluripotent stem cell (iPSC) technologies enable

158 ation of personalized medicine through human induced pluripotent stem cell (iPSC) technology can be a

159 Although induced pluripotent stem cell (iPSC) technology has faci

160 Human-induced pluripotent stem cell (iPSC) technology offers a

161 atient brain specimens, we took advantage of induced pluripotent stem cell (iPSC) technology to model

162 iR-146a was significantly upregulated in SMA induced pluripotent stem cell (iPSC)-derived astrocytes

163 Therapeutic delivery of human induced pluripotent stem cell (iPSC)-derived cardiomyocy

164 and shorten the action potential duration in induced pluripotent stem cell (iPSC)-derived cardiomyocy

165 estigated the therapeutic potential of human induced pluripotent stem cell (iPSC)-derived cells at tw

166 Induced pluripotent stem cell (iPSC)-derived cortical ne

167 inst PD-related genetic mutations in patient induced pluripotent stem cell (iPSC)-derived DAergic neu

168 ntate gyrus (DG) neurons differentiated from induced pluripotent stem cell (iPSC)-derived fibroblasts

169 f cardiofaciocutaneous syndrome (CFC), in an induced pluripotent stem cell (iPSC)-derived model of hu

170 etecting analytes secreted from single human induced pluripotent stem cell (iPSC)-derived neural cell

171 In neuropathology research, induced pluripotent stem cell (iPSC)-derived neurons are

172 tissue engineered blood vessel (TEBV) using induced pluripotent stem cell (iPSC)-derived SMCs from a

173 In recent years, rapid emergence of induced pluripotent stem cells (iPSC) and iPSC-derived c

174 to generate oligodendrocytes (OL) from human induced pluripotent stem cells (iPSC) are currently lack

175 Donor-specific induced pluripotent stem cells (iPSC) can be used to gen

176 ion, we compared mitochondrial metabolism in induced pluripotent stem cells (iPSC) from 5 healthy ind

177 We have generated induced pluripotent stem cells (iPSC) from five HLHS pat

178 In this study, we generated induced pluripotent stem cells (iPSC) from normal human

179 Here we report the differentiation of human induced pluripotent stem cells (iPSC) into microglia-lik

180 lerosis complex (TSC) and LAM (TSC-LAM) into induced pluripotent stem cells (iPSC), followed by selec

181 blasts and motor neurons differentiated from induced pluripotent stem cells (iPSC-MNs) demonstrate ab

182 factors in three wild-type (WT) and three HD induced-pluripotent stem cell (iPSC) lines.

183 We studied induced-pluripotent stem cell (iPSC)-derived megakaryocy

184 igated the innate immune properties of human induced-pluripotent stem cell (iPSC)-derived RPE cells,

185 The discovery of induced pluripotent stem cells (iPSCs) a decade ago, whi

186 embryoid body (EB) cells] from primed-state induced pluripotent stem cells (iPSCs) after a 72-hour t

187 yotrophic lateral sclerosis (ALS) with human induced pluripotent stem cells (iPSCs) aims to reenact e

188 wo complementary approaches, patient-derived induced pluripotent stem cells (iPSCs) and conditional E

189 s in two complex processes: reprogramming to induced pluripotent stem cells (iPSCs) and hematopoiesis

190 s (n = 91) and used their tissue to generate induced pluripotent stem cells (iPSCs) and hepatocyte-li

191 Using neurons derived from PWS patient induced pluripotent stem cells (iPSCs) and mouse models,

192 Here, we used induced pluripotent stem cells (iPSCs) and neural progen

193 mergence of novel technologies such as human induced pluripotent stem cells (iPSCs) and nuclease-medi

194 bility to reprogram adult somatic cells into induced pluripotent stem cells (iPSCs) and the subsequen

195 Induced pluripotent stem cells (iPSCs) are an essential

196 Induced pluripotent stem cells (iPSCs) are being pursued

197 Human induced pluripotent stem cells (iPSCs) are ideal cell so

198 used frontotemporal dementia patient-derived induced pluripotent stem cells (iPSCs) carrying the Tau

199 al progenitors that were differentiated from induced pluripotent stem cells (iPSCs) derived from indi

200 Human induced pluripotent stem cells (iPSCs) derived from indi

201 ysis of murine and human retinoblastomas and induced pluripotent stem cells (iPSCs) derived from muri

202 Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) efficiently gener

203 The recent generation of induced pluripotent stem cells (iPSCs) from a patient wi

204 We generated and characterized induced pluripotent stem cells (iPSCs) from ALS patients

205 In this study, we generated induced pluripotent stem cells (iPSCs) from AML patient

206 We generated induced pluripotent stem cells (iPSCs) from control indi

207 is required for the efficient generation of induced pluripotent stem cells (iPSCs) from murine embry

208 Here we generated de novo induced pluripotent stem cells (iPSCs) from patients har

209 We generated induced pluripotent stem cells (iPSCs) from patients wit

210 urodevelopment, the present study used human induced pluripotent stem cells (iPSCs) from RTT and cont

211 The generation of induced pluripotent stem cells (iPSCs) from the somatic

212 ere we use in vitro differentiation of human induced pluripotent stem cells (iPSCs) generated from pa

213 Induced pluripotent stem cells (iPSCs) generated from pa

214 Genome integrity of induced pluripotent stem cells (iPSCs) has been extensiv

215 Research into induced pluripotent stem cells (iPSCs) has expanded at a

216 ial reparative abilities of EVs derived from induced pluripotent stem cells (iPSCs) have not been dir

217 Earlier studies using human induced pluripotent stem cells (iPSCs) have produced mix

218 Reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) holds enormous pr

219 of human leukocyte antigen (HLA)-homozygous-induced pluripotent stem cells (iPSCs) is considered a f

220 e reprogramming of differentiated cells into induced pluripotent stem cells (iPSCs) is usually achiev

221 enerate and characterise cardiomyocytes from induced pluripotent stem cells (iPSCs) of RA patients.

222 ing, xenotransplantation and genome editing, Induced pluripotent stem cells (iPSCs) present a range o

223 Human-induced pluripotent stem cells (iPSCs) provide a new sou

224 ase (SCD) genetic defect in patient-specific induced Pluripotent Stem Cells (iPSCs) provides a potent

225 functional CS neural networks from human CS induced pluripotent stem cells (iPSCs) providing a new t

226 Induced pluripotent stem cells (iPSCs) show variable met

227 , we show that astrocytes derived from human induced pluripotent stem cells (iPSCs) support the repli

228 generated from schizophrenic patient-derived induced pluripotent stem cells (iPSCs) that have been de

229 form based on a genetically diverse panel of induced pluripotent stem cells (iPSCs) that reproduces s

230 entified variants through differentiation of induced pluripotent stem cells (iPSCs) to study cellular

231 Steering the differentiation of induced pluripotent stem cells (iPSCs) toward specific c

232 ebral organoids derived from control and MDS-induced pluripotent stem cells (iPSCs) using time-lapse

233 Induced pluripotent stem cells (iPSCs) were generated fr

234 Here, induced pluripotent stem cells (iPSCs) were used to esta

235 organoids derived from schizophrenia patient induced pluripotent stem cells (iPSCs) with a DISC1 muta

236 rivation of functional airway organoids from induced pluripotent stem cells (iPSCs) would provide val

237 Induced pluripotent stem cells (iPSCs), and cells derive

238 sing VCP knockdown neuroblastoma cell lines, induced pluripotent stem cells (iPSCs), and iPSC-derived

239 The patient-derived induced pluripotent stem cells (iPSCs), carrying these C

240 We show that during reprogramming to induced pluripotent stem cells (iPSCs), fibroblasts from

241 h as human mesenchymal stem cells (MSCs) and induced pluripotent stem cells (iPSCs), has not been ass

242 rst established a liver organoid using human induced pluripotent stem cells (iPSCs), mesenchymal stem

243 Using patient-specific induced pluripotent stem cells (iPSCs), we generated MCT

244 mechanisms of somatic reprogramming to human induced pluripotent stem cells (iPSCs), we have establis

245 pectedly, stem cells as well as reprogrammed induced pluripotent stem cells (iPSCs), where the protei

246 nd cMYC (OSKM) reprograms somatic cells into induced pluripotent stem cells (iPSCs).

247 tiated human embryonic stem cells (hESCs) or induced pluripotent stem cells (iPSCs).

248 om endoderm that has been derived from human induced pluripotent stem cells (iPSCs).

249 CRISPRi) to repress gene expression in human induced pluripotent stem cells (iPSCs).

250 etal NPCs as well as NPCs derived from human induced pluripotent stem cells (iPSCs).

251 ted later during the transition to bona fide induced pluripotent stem cells (iPSCs).

252 esearch and clinical interest, such as human induced pluripotent stem cells (iPSCs).

253 cluding six transformed cell lines and human induced pluripotent stem cells (iPSCs).

254 atocyte characteristics can be produced from induced pluripotent stem cells (iPSCs).

255 Two recent technologies, induced-pluripotent stem cells (iPSCs) and direct somati

256 eprogramming by transcription factors (i.e., induced pluripotent stem cells, iPSCs) or by somatic cel

257 pproach using macrophages derived from human induced pluripotent stem cells (iPSdMs) to study macroph

258 ing cells from human embryonic stem cells or induced pluripotent stem cells is at present close to re

259 generated from multiple human embryonic and induced pluripotent stem cell lines and have potential a

260 S) in Parkinson's Disease, we have generated induced Pluripotent Stem Cell lines from early onset Par

261 s analyzing large-scale collections of human induced pluripotent stem cell lines provide valuable ins

262 Isogenic induced pluripotent stem cell lines showed greater varia

263 ence is more common in ES cell lines than in induced pluripotent stem cell lines.

264 The advent of induced pluripotent stem cells means that it may ultimat

265 enerated a vascular model derived from human induced pluripotent stem cells (MFS-hiPSCs).

266 e endothelial-lineage specification of mouse induced-pluripotent stem cells (miPSCs).

267 ology, we established a ChAc patient-derived induced pluripotent stem cell model and an efficient dif

268 to nonsyndromic autism pathophysiology using induced pluripotent stem cells modeling disease technolo

269 Here we show, using murine and human induced pluripotent stem cell models, that RPGR interact

270 ere, we reprogrammed fibroblasts to generate induced pluripotent stem cells, neural progenitor cells

271 ed the findings in C9ALS/FTD fibroblasts and induced pluripotent stem cell neurons.

272 ere we demonstrate the generation from human induced pluripotent stem cells of a self-formed ectoderm

273 yonic fibroblasts, embryonic stem cells, and induced pluripotent stem cells of laboratory rats.

274 Induced pluripotent stem cells offer a new way to recapi

275 ed from human neural progenitor cells, human induced pluripotent stem cells, or in primary rat cortic

276 Human induced pluripotent stem cells, particularly derived fro

277 ing skeletal muscle efficiently from porcine induced pluripotent stem cells (piPSC) in vitro thereby

278 from brain neurons, embryonic stem cells and induced pluripotent stem cells, primordial germ cells an

279 s and midbrain dopamine neurons derived from induced pluripotent stem cells, providing a novel model

280 ssue-engineering approach with embryonic and induced pluripotent stem cells (PSCs) to generate human

281 Here, we use human induced pluripotent stem cell-retinal pigment epithelium

282 Targeted differentiation of patient-derived induced pluripotent stem cells showed a reduced expansio

283 Patient-derived induced pluripotent stem cells showed alternative splici

284 and RA or retinol promote the derivation of induced pluripotent stem cells synergistically and enhan

285 etic Association Studies Consortium has used induced pluripotent stem cell technology to study the ef

286 ocytes that are derived from mouse and human induced pluripotent stem cells through a mechanism that

287 ning them with NPCs and neurons derived from induced pluripotent stem cells to create patient-specifi

288 ells that had been differentiated from human-induced pluripotent stem cells to generate a human-induc

289 We used fibroblast-derived induced pluripotent stem cells to generate retinal pigme

290 ensional retinal tissue from patient-derived induced pluripotent stem cells to identify how CEP290 mu

291 cardiomyocytes generated from embryonic and induced pluripotent stem cells, to model newly formed ce

292 ns of early development in TSC, we generated induced pluripotent stem cells using dermal fibroblasts

293 Endothelial cells differentiated from induced pluripotent stem cells were compared with pulmon

294 Induced pluripotent stem cells were derived from a clini

295 Whole-genome sequencing and induced pluripotent stem cells were used to examine a fa

296 reprogrammed from 3 persons with STGD1 into induced pluripotent stem cells, which were differentiate

297 e generated CSC-like cells by treating mouse induced pluripotent stem cells with conditioned medium f

298 show that human cardiomyocytes derived from induced pluripotent stem cells with enhanced expression

299 ions, both human cardiomyocytes derived from induced pluripotent stem cells with enhanced Kir2.1 expr

300 lls with an extra human chromosome and human induced pluripotent stem cells with trisomy 21, as well